2008年碩士畢業(yè)于貴陽(yáng)醫(yī)學(xué)院，2020年博士畢業(yè)于四川大學(xué)華西醫(yī)院，2011年在中國(guó)醫(yī)學(xué)院科學(xué)院腫瘤醫(yī)院進(jìn)修學(xué)習(xí)1年，從事腫瘤臨床、教學(xué)、科研工作10余年，對(duì)中樞神經(jīng)系統(tǒng)腫瘤、頭頸腫瘤、黑色素瘤、淋巴瘤等惡性腫瘤的放化療、靶向治療、免疫治療有豐富的臨床經(jīng)驗(yàn)。以第一/通訊作者發(fā)表學(xué)術(shù)論文10余篇，其中在HEAD & NECK、J Cell Biochem等雜志發(fā)表SCI 6篇，主持課題3項(xiàng)。現(xiàn)擔(dān)任中國(guó)抗癌協(xié)會(huì)鼻咽癌專業(yè)委員會(huì)青年委員中國(guó)抗癌協(xié)會(huì)腫瘤支持治療專業(yè)委員會(huì)青年委員，中國(guó)醫(yī)師協(xié)會(huì)放射腫瘤治療醫(yī)師分會(huì)鼻咽癌放療學(xué)組委員，西部放射治療協(xié)會(huì)頭頸腫瘤專業(yè)委員會(huì)委員，貴州省抗癌協(xié)會(huì)鼻咽癌專業(yè)委員會(huì)委員，遵義市醫(yī)學(xué)會(huì)放射腫瘤治療學(xué)分會(huì)常務(wù)委員，遵義市醫(yī)學(xué)會(huì)腫瘤學(xué)分會(huì)委員，遵義市醫(yī)學(xué)會(huì)核醫(yī)學(xué)分會(huì)委員。

相關(guān)文獻(xiàn)：

近5年發(fā)表的論文：

1、Juan Ye#, Lin Zhang#, Zhongwen Li, Runduan Lin, Yiling Song, Huanhe Ni, Xiaoxia Gou*, Rongzhang Xie*.High expression of MDM2 and the p53 protein is predictive biomarkers for poor prognosis of oesophageal squamous cell carcinoma. Cancer Management and Research. 2021, 13:2733-2744.

2、Xiaoxia Gou#, Baofeng Duan#, Huashan Shi#, Lei Qin, Jianghong Xiao, Nianyong Chen*. The relations of dosimetric parameters with long-term outcomes and late toxicities in adavanced T-stage nasopharyngeal carcinoma with IMRT. Head & neck, 2020,42(1):85–92.

3、Guihai Zhang#*, Erxi Fan#, Guojun Yue, Qiuyue Zhong, Yu Shuai, Mingna Wu, Guangyong Feng, Qiying Chen, Xiaoxia Gou*. Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer. Journal of Cellular Biochemistry, 2019;.

4、Guihai Zhang#*, Erxi Fan#, Qiuyue Zhong, Guangyong Feng, Yu Shuai, Mingna Wu, Qiying Chen, Xiaoxia Gou*. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer. Human Genomics, 2019,13 (1): 36.

5、茍小霞、阮培剛、徐穎、王彥哲、徐暉、曾令秀、張貴海*. 基于數(shù)據(jù)挖掘分析NAMPT在腦膠質(zhì)瘤中的表達(dá)及意義[J].腫瘤預(yù)防與治療. 2019;32(3):221-227.

6、Xiaoxia Gou, Feng Jin*, Weili Wu, Jinhua Long, Yuanyuan Li, Xiuyun Gong, Guoyan Chen, Xiaoxiao Chen, Lina Liu. Induction chronomodulated chemotherapy plus radiotherapy for nasopharyngeal carcinoma: A Phase II prospective randomized study. Journal of Cancer Research and Therapeutics, 2018, 14(7):1613-9.

7、陳敏 茍小霞*（通訊作者） 陳芳 田昕 郭辰睿.PEG 在頭頸部腫瘤放療患者中的應(yīng)用及相關(guān)療效觀察.醫(yī)藥前沿2018,8(16):171-172.2018年6月

8、茍小霞、岳國(guó)軍、葉娟、徐暉、田昕、張貴海*.微課在腫瘤學(xué)教學(xué)中的應(yīng)用[J].中國(guó)高等醫(yī)學(xué)教育.2018（1）,1:20-21. 卷（期）2018年1月15日

9、Xiaoxia Gou#，Haixia Chen#，F(xiàn)eng Jin*, Weili Wu, Yuanyuan Li, Jinhua Long, Xiuyun Gong, Mengyalan Luo, Ting Bi, Zhuolin Li, Qianyong He. Expression of CD147、MMP-2 and MMP-9 in laryyngeal carcinoma and its correlation with poor prognosis.Pathology and Oncology Research,2014,20(2):475-481.